Barbara Mühlemann

3.7k total citations · 3 hit papers
19 papers, 630 citations indexed

About

Barbara Mühlemann is a scholar working on Infectious Diseases, Modeling and Simulation and Animal Science and Zoology. According to data from OpenAlex, Barbara Mühlemann has authored 19 papers receiving a total of 630 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 5 papers in Modeling and Simulation and 4 papers in Animal Science and Zoology. Recurrent topics in Barbara Mühlemann's work include SARS-CoV-2 and COVID-19 Research (15 papers), SARS-CoV-2 detection and testing (7 papers) and COVID-19 epidemiological studies (5 papers). Barbara Mühlemann is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (15 papers), SARS-CoV-2 detection and testing (7 papers) and COVID-19 epidemiological studies (5 papers). Barbara Mühlemann collaborates with scholars based in Germany, United Kingdom and United States. Barbara Mühlemann's co-authors include Christian Drosten, Victor M. Corman, Andi Krumbholz, Marie Luisa Schmidt, Marta Żuchowski, Tobias Bleicker, Terry C. Jones, Marcel A. Müller, Jan Felix Drexler and Wendy K. Jo and has published in prestigious journals such as Science, PLoS Biology and Genome biology.

In The Last Decade

Barbara Mühlemann

16 papers receiving 615 citations

Hit Papers

Estimating infectiousness throughout SARS-CoV-2 infection... 2021 2026 2022 2024 2021 2021 2024 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Estimating infectiousness throughout SARS-CoV-2 infection course
    2021 283 citations Terry C. Jones, Guido Biele et al. Science profile →
  2. Comparison of seven commercial SARS-CoV-2 rapid point-of-care antigen tests: a single-centre laboratory evaluation study
    2021 226 citations Victor M. Corman, Verena Haage et al. The Lancet Microbe profile →
  3. Humoral immune escape by current SARS-CoV-2 variants BA.2.86 and JN.1, December 2023
    2024 37 citations Lara M. Jeworowski, Barbara Mühlemann et al. Eurosurveillance profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barbara Mühlemann Germany 7 514 192 112 112 87 19 630
Marie Luisa Schmidt Germany 10 592 1.2× 190 1.0× 127 1.1× 120 1.1× 107 1.2× 16 704
Niko Kohmer Germany 11 630 1.2× 145 0.8× 101 0.9× 62 0.6× 56 0.6× 24 696
Marta Żuchowski Germany 5 433 0.8× 186 1.0× 96 0.9× 98 0.9× 78 0.9× 7 539
Olha Puhach Switzerland 8 464 0.9× 71 0.4× 71 0.6× 112 1.0× 119 1.4× 9 592
Jan Van Elslande Belgium 10 674 1.3× 85 0.4× 60 0.5× 96 0.9× 58 0.7× 24 764
Eamon O’Murchu Ireland 3 375 0.7× 99 0.5× 44 0.4× 73 0.7× 55 0.6× 5 445
Garrett A. Perchetti United States 15 747 1.5× 319 1.7× 187 1.7× 23 0.2× 157 1.8× 21 874
Moran Szwarcwort‐Cohen Israel 9 409 0.8× 137 0.7× 88 0.8× 48 0.4× 62 0.7× 19 505
Kazuyasu Miyoshi Japan 7 783 1.5× 186 1.0× 208 1.9× 63 0.6× 60 0.7× 16 927
Talitha Veith Germany 6 292 0.6× 40 0.2× 102 0.9× 89 0.8× 227 2.6× 8 556

Countries citing papers authored by Barbara Mühlemann

Since Specialization
Citations

This map shows the geographic impact of Barbara Mühlemann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Mühlemann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Mühlemann more than expected).

Fields of papers citing papers by Barbara Mühlemann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Mühlemann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Mühlemann. The network helps show where Barbara Mühlemann may publish in the future.

Co-authorship network of co-authors of Barbara Mühlemann

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Mühlemann. A scholar is included among the top collaborators of Barbara Mühlemann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Mühlemann. Barbara Mühlemann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Jeworowski, Lara M., Barbara Mühlemann, Marie Luisa Schmidt, et al.. (2025). Humoral immunity to current variants of SARS-CoV-2 in exposed adults, September 2023 to September 2024. mBio. 16(10). e0161825–e0161825.
2.
Rössler, Annika, Antonia Netzl, Ninaad Lasrado, et al.. (2025). Nonhuman primate antigenic cartography of SARS-CoV-2. Cell Reports. 44(1). 115140–115140. 5 indexed citations
3.
Rössler, Annika, Antonia Netzl, Ludwig Knabl, et al.. (2024). Direct comparison of SARS-CoV-2 variant specific neutralizing antibodies in human and hamster sera. npj Vaccines. 9(1). 85–85. 3 indexed citations
4.
Jones, Terry C., Barbara Mühlemann, Marie Luisa Schmidt, et al.. (2024). SARS-CoV-2 rapid antigen test sensitivity and viral load in newly symptomatic hospital employees in Berlin, Germany, December, 2020 to February, 2022: an observational study. The Lancet Microbe. 5(6). e538–e546. 1 indexed citations
5.
Hassan, Ahmed M., Barbara Mühlemann, Jordi Rodon, et al.. (2024). Ongoing Evolution of Middle East Respiratory Syndrome Coronavirus, Saudi Arabia, 2023–2024. Emerging infectious diseases. 31(1). 57–65. 6 indexed citations
6.
Jeworowski, Lara M., Barbara Mühlemann, Marie Luisa Schmidt, et al.. (2024). Humoral immune escape by current SARS-CoV-2 variants BA.2.86 and JN.1, December 2023. Eurosurveillance. 29(2). 37 indexed citations breakdown →
7.
Katz, Mark A., Michael Herdman, Barbara Mühlemann, et al.. (2023). The effectiveness of primary series CoronaVac vaccine in preventing COVID‐19 illness: A prospective cohort study among healthcare workers in Azerbaijan, May–November 2021. Influenza and Other Respiratory Viruses. 17(10). e13147–e13147. 2 indexed citations
8.
Kota, Majlinda, Barbara Mühlemann, Christian Drosten, et al.. (2023). Primary Series and Booster Coronavirus Disease 2019 Vaccine Effectiveness in a Cohort of Healthcare Workers in Albania During a BA.1 and BA.2 Variant Period, January–May 2022. Open Forum Infectious Diseases. 10(10). ofad479–ofad479.
9.
Veith, Talitha, Tobias Bleicker, Monika Eschbach-Bludau, et al.. (2023). Non-structural genes of novel lemur adenoviruses reveal codivergence of virus and host. Virus Evolution. 9(1). vead024–vead024. 1 indexed citations
10.
11.
Susat, Julian, Barbara Mühlemann, Michael Francken, et al.. (2022). Pathogen genomics study of an early medieval community in Germany reveals extensive co-infections. Genome biology. 23(1). 250–250. 10 indexed citations
12.
Oliveira-Filho, Edmilson Ferreira de, Bladimiro Rincón‐Orozco, Barbara Mühlemann, et al.. (2022). Effectiveness of Naturally Acquired and Vaccine-Induced Immune Responses to SARS-CoV-2 Mu Variant. Emerging infectious diseases. 28(8). 1708–1712. 3 indexed citations
13.
Mühlemann, Barbara, Marie Luisa Schmidt, Peter Menzel, et al.. (2022). SARS-CoV-2 Rapid Antigen Test Sensitivity and Viral Load in Freshly Symptomatic Hospital Employees, December 2020 to February 2022. SSRN Electronic Journal. 5 indexed citations
14.
Jones, Terry C., Guido Biele, Barbara Mühlemann, et al.. (2021). Estimating infectiousness throughout SARS-CoV-2 infection course. Science. 373(6551). 283 indexed citations breakdown →
15.
Amanat, Fatima, Shirin Strohmeier, Philip Meade, et al.. (2021). Vaccination with SARS-CoV-2 variants of concern protects mice from challenge with wild-type virus. PLoS Biology. 19(12). e3001384–e3001384. 10 indexed citations
16.
Corman, Victor M., Verena Haage, Tobias Bleicker, et al.. (2021). Comparison of seven commercial SARS-CoV-2 rapid point-of-care antigen tests: a single-centre laboratory evaluation study. The Lancet Microbe. 2(7). e311–e319. 226 indexed citations breakdown →
17.
Widera, Marek, Barbara Mühlemann, Victor M. Corman, et al.. (2021). Surveillance of SARS-CoV-2 in Frankfurt am Main from October to December 2020 Reveals High Viral Diversity Including Spike Mutation N501Y in B.1.1.70 and B.1.1.7. Microorganisms. 9(4). 748–748. 8 indexed citations
18.
Müller, Nadine, Neil J. Saad, Barbara Mühlemann, et al.. (2020). Severe Acute Respiratory Syndrome Coronavirus 2 Outbreak Related to a Nightclub, Germany, 2020. Emerging infectious diseases. 27(2). 645–648. 18 indexed citations
19.
Boheemen, Sander van, Terry C. Jones, Barbara Mühlemann, et al.. (2014). Cidofovir Gel as Treatment of Follicular Spicules in Multiple Myeloma. JAMA Dermatology. 151(1). 82–82. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marie Luisa Schmidt Breakdown of academic impact, for papers by Niko Kohmer Breakdown of academic impact, for papers by Marta Żuchowski Breakdown of academic impact, for papers by Olha Puhach Breakdown of academic impact, for papers by Jan Van Elslande Breakdown of academic impact, for papers by Eamon O’Murchu Breakdown of academic impact, for papers by Garrett A. Perchetti Breakdown of academic impact, for papers by Moran Szwarcwort‐Cohen Breakdown of academic impact, for papers by Kazuyasu Miyoshi Breakdown of academic impact, for papers by Talitha Veith
Rankless by CCL
2026